Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients. | Cardiovasc Drugs Ther | 2023 | 35460392 | PubTator, text mining | PubMed |
| Estrogens desensitize MCF-7 breast cancer cells to apelin-induced autophagy and enhanced growth under estrogen starvation: a possible implication in endocrine resistance. | Cell Mol Biol (Noisy-le-grand) | 2022 | 36905266 | PubTator, text mining | PubMed |
| Human-gained heart enhancers are associated with species-specific cardiac attributes. | Nat Cardiovasc Res | 2022 | 36817700 | PubTator, text mining | PubMed |
| Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis. | Front Endocrinol (Lausanne) | 2022 | 36714603 | PubTator, text mining | PubMed |
| The Vasculature in Pulmonary Fibrosis. | Curr Tissue Microenviron Rep | 2022 | 36712832 | PubTator, text mining | PubMed |
| Identification of pathological-related and diagnostic potential circular RNAs in Stanford type A aortic dissection. | Front Cardiovasc Med | 2022 | 36712253 | PubTator, text mining | PubMed |
| Apelin-17 to diagnose idiopathic pulmonary arterial hypertension: A biomarker study. | Front Physiol | 2022 | 36685176 | PubTator, text mining | PubMed |
| Application of Single-Cell RNA Sequencing in Ovarian Development. | Biomolecules | 2022 | 36671432 | PubTator, text mining | PubMed |
| Discovery of the inhibitor of DNA binding 1 as a novel marker for radioresistance in pancreatic cancer using genome-wide RNA-seq. | Cancer Drug Resist | 2022 | 36627902 | PubTator, text mining | PubMed |
| The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect? | Cells | 2022 | 36611944 | PubTator, text mining | PubMed |
| Elabela: Negative Regulation of Ferroptosis in Trophoblasts via the Ferritinophagy Pathway Implicated in the Pathogenesis of Preeclampsia. | Cells | 2022 | 36611895 | PubTator, text mining | PubMed |
| Identification of candidate genes associated with clinical onset of Alzheimer's disease. | Front Neurosci | 2022 | 36605552 | PubTator, text mining | PubMed |
| Evaluation of angiogenic apelin/apelin receptor axis in normal prostate, high grade prostatic intraepithelial neoplasia and prostatic adenocarcinoma. | Malays J Pathol | 2022 | 36591713 | PubTator, text mining | PubMed |
| Apelin as a Candidate for Hypertension Management; a Systematic Review and Meta-Analysis on Animal Studies. | Arch Acad Emerg Med | 2022 | 36590652 | PubTator, text mining | PubMed |
| Conventional Ameloblastoma. A Case Report with Microarray and Bioinformatic Analysis. | Diagnostics (Basel) | 2022 | 36553196 | PubTator, text mining | PubMed |
| Potential Value of Visfatin, Omentin-1, Nesfatin-1 and Apelin in Renal Cell Carcinoma (RCC): A Systematic Review and Meta-Analysis. | Diagnostics (Basel) | 2022 | 36553076 | PubTator, text mining | PubMed |
| A Review of the Roles of Apelin and ELABELA Peptide Ligands in Cardiovascular Disease, Including Heart Failure and Hypertension. | Med Sci Monit | 2022 | 36523134 | PubTator, text mining | PubMed |
| Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms. | Front Hum Neurosci | 2022 | 36504622 | PubTator, text mining | PubMed |
| Identification of metabolism-related genes for predicting peritoneal metastasis in patients with gastric cancer. | BMC Genom Data | 2022 | 36503378 | PubTator, text mining | PubMed |
| Editorial: Biomarkers to disentangle the physiological from pathological brain aging, volume II. | Front Aging Neurosci | 2022 | 36483112 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=21